A detailed history of Assetmark, Inc transactions in Natera, Inc. stock. As of the latest transaction made, Assetmark, Inc holds 7,353 shares of NTRA stock, worth $1.19 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares
7,353
Previous 7,203 2.08%
Holding current value
$1.19 Million
Previous $780,000 19.74%
% of portfolio
0.0%
Previous 0.0%

Shares

16 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 01, 2024

BUY
$97.75 - $129.67 $14,662 - $19,450
150 Added 2.08%
7,353 $934,000
Q2 2024

Aug 13, 2024

BUY
$85.28 - $112.6 $259,677 - $342,867
3,045 Added 73.23%
7,203 $780,000
Q1 2024

May 06, 2024

SELL
$59.21 - $92.9 $62,999 - $98,845
-1,064 Reduced 20.38%
4,158 $380,000
Q4 2023

Feb 09, 2024

BUY
$37.55 - $62.64 $49,678 - $82,872
1,323 Added 33.93%
5,222 $327,000
Q3 2023

Oct 27, 2023

BUY
$43.4 - $62.52 $23,956 - $34,511
552 Added 16.49%
3,899 $172,000
Q2 2023

Aug 11, 2023

SELL
$47.08 - $55.16 $3,766 - $4,412
-80 Reduced 2.33%
3,347 $162,000
Q1 2023

May 05, 2023

BUY
$36.57 - $58.29 $30,023 - $47,856
821 Added 31.5%
3,427 $190,000
Q4 2022

Feb 10, 2023

BUY
$34.17 - $47.91 $44,147 - $61,899
1,292 Added 98.33%
2,606 $104,000
Q3 2022

Nov 01, 2022

BUY
$36.93 - $56.68 $16,286 - $24,995
441 Added 50.52%
1,314 $58,000
Q2 2022

Aug 03, 2022

BUY
$28.13 - $44.54 $11,870 - $18,795
422 Added 93.57%
873 $31,000
Q1 2022

May 13, 2022

SELL
$30.32 - $91.33 $45,570 - $137,268
-1,503 Reduced 76.92%
451 $18,000
Q4 2021

Feb 14, 2022

BUY
$86.26 - $119.0 $152,507 - $210,392
1,768 Added 950.54%
1,954 $182,000
Q3 2021

Nov 12, 2021

BUY
$100.17 - $126.36 $18,631 - $23,502
186 New
186 $21,000
Q1 2020

May 12, 2020

SELL
$17.27 - $40.17 $535 - $1,245
-31 Closed
0 $0
Q4 2019

Feb 11, 2020

BUY
$32.1 - $40.4 $32 - $40
1 Added 3.33%
31 $1,000
Q3 2019

Nov 13, 2019

BUY
$25.38 - $34.89 $761 - $1,046
30 New
30 $1,000

Others Institutions Holding NTRA

About Natera, Inc.


  • Ticker NTRA
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 96,957,400
  • Market Cap $15.7B
  • Description
  • Natera, Inc., a diagnostics company, develops and commercializes molecular testing services worldwide. It offers Panorama, a non-invasive prenatal test that screens for chromosomal abnormalities of a fetus with a blood draw from the mother, as well as twin pregnancies for zygosity; Vistara, a single-gene mutations screening test to identify sing...
More about NTRA
Track This Portfolio

Track Assetmark, Inc Portfolio

Follow Assetmark, Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Assetmark, Inc, based on Form 13F filings with the SEC.

News

Stay updated on Assetmark, Inc with notifications on news.